225 related articles for article (PubMed ID: 18570371)
1. Hot-spots-guided receptor-based pharmacophores (HS-Pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores.
Barillari C; Marcou G; Rognan D
J Chem Inf Model; 2008 Jul; 48(7):1396-410. PubMed ID: 18570371
[TBL] [Abstract][Full Text] [Related]
2. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application.
Baroni M; Cruciani G; Sciabola S; Perruccio F; Mason JS
J Chem Inf Model; 2007; 47(2):279-94. PubMed ID: 17381166
[TBL] [Abstract][Full Text] [Related]
3. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
Kellenberger E; Foata N; Rognan D
J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
[TBL] [Abstract][Full Text] [Related]
4. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
Klabunde T; Giegerich C; Evers A
J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
[TBL] [Abstract][Full Text] [Related]
5. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
6. GPCR structure-based virtual screening approach for CB2 antagonist search.
Chen JZ; Wang J; Xie XQ
J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
[TBL] [Abstract][Full Text] [Related]
7. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring.
Zhang Q; Muegge I
J Med Chem; 2006 Mar; 49(5):1536-48. PubMed ID: 16509572
[TBL] [Abstract][Full Text] [Related]
8. Novel method for generating structure-based pharmacophores using energetic analysis.
Salam NK; Nuti R; Sherman W
J Chem Inf Model; 2009 Oct; 49(10):2356-68. PubMed ID: 19761201
[TBL] [Abstract][Full Text] [Related]
9. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
10. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.
Wolber G; Langer T
J Chem Inf Model; 2005; 45(1):160-9. PubMed ID: 15667141
[TBL] [Abstract][Full Text] [Related]
11. Multiple-ligand-based virtual screening: methods and applications of the MTree approach.
Hessler G; Zimmermann M; Matter H; Evers A; Naumann T; Lengauer T; Rarey M
J Med Chem; 2005 Oct; 48(21):6575-84. PubMed ID: 16220974
[TBL] [Abstract][Full Text] [Related]
12. Ph4Dock: pharmacophore-based protein-ligand docking.
Goto J; Kataoka R; Hirayama N
J Med Chem; 2004 Dec; 47(27):6804-11. PubMed ID: 15615529
[TBL] [Abstract][Full Text] [Related]
13. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
[TBL] [Abstract][Full Text] [Related]
14. Minimizing false positives in kinase virtual screens.
Perola E
Proteins; 2006 Aug; 64(2):422-35. PubMed ID: 16708364
[TBL] [Abstract][Full Text] [Related]
15. Snooker: a structure-based pharmacophore generation tool applied to class A GPCRs.
Sanders MP; Verhoeven S; de Graaf C; Roumen L; Vroling B; Nabuurs SB; de Vlieg J; Klomp JP
J Chem Inf Model; 2011 Sep; 51(9):2277-92. PubMed ID: 21866955
[TBL] [Abstract][Full Text] [Related]
16. Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening.
Sato T; Honma T; Yokoyama S
J Chem Inf Model; 2010 Jan; 50(1):170-85. PubMed ID: 20038188
[TBL] [Abstract][Full Text] [Related]
17. Predicting multiple ligand binding modes using self-consistent pharmacophore hypotheses.
Wallach I; Lilien R
J Chem Inf Model; 2009 Sep; 49(9):2116-28. PubMed ID: 19711952
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
Kumar A; Siddiqi MI
J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
[TBL] [Abstract][Full Text] [Related]
19. Managing protein flexibility in docking and its applications.
B-Rao C; Subramanian J; Sharma SD
Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
[TBL] [Abstract][Full Text] [Related]
20. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.
Stroganov OV; Novikov FN; Stroylov VS; Kulkov V; Chilov GG
J Chem Inf Model; 2008 Dec; 48(12):2371-85. PubMed ID: 19007114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
